secwatch / observer
8-K filed November 13, 2023, 6:59 PM ET ticker BIVI CIK 0001580149
other confidence high sentiment neutral materiality 0.10

BioVie shareholders elect directors and ratify EisnerAmper as auditor

BIOVIE INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

BIOVIE INC. shareholders approved Election of Directors at the 2023-11-08 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-11-08
Exact text from the filing
Stockholders elected all of the Company’s nominees for director for one-year terms expiring at the next annual meeting of stockholders upon election and qualification of their successors. The voting results were as follows: For Withhold Broker Non-Vote (1) CUONG DO 24,871,797 74,353 4,528,595 (2) JIM LANG 24,557,658 388,492 4,528,595 (3) MICHAEL SHERMAN 24,630,002 316,148 4,528,595 (4) RICHARD J. BERMAN 24,526,699 419,451 4,528,595 (5) STEVE GORLIN 24,602,592 343,558 4,528,595 (6) ROBERT HARIRI, M.D. PHD 24,774,046 172,104 4,528,595 (7) SIGMUND ROGICH 24,867,955 78,195 4,528,595
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

BIOVIE INC. shareholders approved Approval and Ratification of Auditors at the 2023-11-08 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-11-08
Exact text from the filing
Stockholders approved and ratified the appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the 2024 fiscal year. The voting results were as follows: For Against Abstain Broker Non-Vote 29,275,023 180,567 19,155 4,528,595
View on SEC.gov

1500 shareholder votes filed in the last 30 days. Browse all shareholder votes →

BIOVIE INC. filing history →

Source: SEC EDGAR
accession 0001520138-23-000488
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.